Role of TREM2 in neuroinflammation

Exp Neurol. 2026 Feb:396:115547. doi: 10.1016/j.expneurol.2025.115547. Epub 2025 Nov 8.

Abstract

Triggering receptor expressed on myeloid cells 2 (TREM2) is cell surface transmembrane receptor of the TREM family, predominantly expressed on microglia within the central nervous system (CNS). Accumulating evidence has highlighted a critical role for microglial TREM2 in modulating inflammatory signaling pathways, thereby influencing the course of neuroinflammation - a central pathological hallmark of various neurodegenerative and CNS disorders. In this review, we aim to elucidate the molecular mechanisms by which TREM2 regulates neuroinflammatory processes, with a particular focus on the most recent advances in the field. A deeper understanding of TREM2-mediated signaling may uncover novel therapeutic targets and pathways with significant translational potential for treatment of CNS diseases.

Keywords: Alzheimer's and Parkinson's diseases; Brain hemorrhage; Microglia; Neurodegenerative diseases; Neuroinflammation; TREM2.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Membrane Glycoproteins* / metabolism
  • Microglia / metabolism
  • Neuroinflammatory Diseases* / metabolism
  • Neuroinflammatory Diseases* / pathology
  • Receptors, Immunologic* / metabolism
  • Signal Transduction / physiology

Substances

  • Receptors, Immunologic
  • Membrane Glycoproteins
  • TREM2 protein, human